Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 6Precancerous Conditions 1Lung Neoplasms 1Castration-resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1Adult Solid Neoplasm 1Adenomatous Polyps 1Adenoma 1

Interventions

tremelimumab 1peginterferon alfa-2b 1Zoledronic Acid 1Zidovudine 1Whole-Body Irradiation 1Valproic Acid 1Tetradecanoylphorbol Acetate 1Sodium Chloride 1Selenium 1Rosuvastatin Calcium 1Rituximab 1Ribavirin 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Observation 1Moxifloxacin 1Morphine 1Microarray Analysis 1Methadone 1Laser Therapy 1Interferon alpha-2 1Infliximab 1Gene Expression Profiling 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Flow Cytometry 1Fentanyl 1Colposcopy 1Ciprofloxacin 1Chromatography, High Pressure Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Precancerous Conditions × Calcitriol × Clear all
NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Rutgers, The State University of New Jersey

Phase 2 Terminated
12 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡